Rockefeller University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Rockefeller University sits in the top decile of US sponsors by registered trial count (#222 of 15,742 sponsors by registered trial count).
Rockefeller University: 117 sponsored US clinical trials, 5 recruiting.
Rockefeller University sponsors 117 registered US clinical trials on ClinicalTrials.gov, 5 of them currently recruiting, and 92 completed. 7 of these trials are in Phase 3-4 (later-stage) and 43 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 5 trials.
Top-decile sponsor footprint
Rockefeller University ranks in the top decile of sponsors by registered trial count (#222 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
92 of 109 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (84.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
117 total, page 2 of 3
An Open Label Study of IgG Fc Glycan Composition in Human Immunity
NCT01967238
Pilot Study Characterizing Adipose Tissue Leukocytes by Flow Cytometry/Microscopy in Lean, Obese and Psoriatic Subjects
NCT01856647
Correlates and Consequences of Increased Immune Activation in Injection Drug Users
NCT01831284
Mercury Versus Automated Blood Pressure Monitoring
NCT01753895
Treatment of Cutaneous Metastases With Diphenylcyclopropenone (DPCP)
NCT01711684
Resveratrol and the Metabolic Syndrome
NCT01714102
Diet Induced Weight Loss to Reduce Inflammation in Obese Women
NCT01699906
The Effect of Oral Vitamin D Versus Narrow-Band UV-B Exposure on the Lipid Profile
NCT01688102
Immune Reactions in Contact Dermatitis Affected Skin
NCT01546298
Analysis of Diphenylcyclopropenone (DPCP) in Normals
NCT01452594
The Effects of GLA on Human Volunteers
NCT01397604
Polyinosinic-Polycytidylic Acid-poly-L-lysine Carboxymethylcellulose (Poly-ICLC) in Healthy Volunteers
NCT01299662
Effect of Metabolic State on Anxiety in Human Subjects
NCT01322243
Psoriasis Inflammation and Systemic Co Morbidities
NCT01170715
Cell Responses to IFN-gamma
NCT01317017
Reversal of Epidermal Phenotype in Severe Atopic Dermatitis With Cyclosporine Therapy
NCT01149759
DCVax Plus Poly ICLC in Healthy Volunteers
NCT01127464
A Pilot Study of Docosahexaenoic Acid (DHA) in Obese Menopausal Women
NCT01127867
Genetic Basis of Odor Discrimination
NCT01039935
Study to Evaluate the Safety and Immunogenicity of Poly ICLC (Hiltonol) in Healthy Volunteers
NCT01012700
Pilot Study to Assess Gut Mucosal B Cells in Individuals With HCV and HIV
NCT01040039
The Effect of Vitamin D Repletion on Small Low Density Lipoprotein (LDL) Particle Number in Subjects at Elevated Cardiovascular Risk
NCT01008384
Metabolic Features of Post-Myopathy Patients Associated With Statin Treatment
NCT01040650
Isocaloric Dietary Interventions for Insulin Resistance and the Metabolic Syndrome
NCT01040663
Effects of a Western-type Diet on Colorectal Inflammation
NCT00866450
Quality of Life in Patients With Statin-Associated Myopathy
NCT00850460
Narrowband UVB Phototherapy in the Treatment of Psoriasis Vulgaris
NCT00844363
Assessment of Bleeding Symptoms in Normal Individuals Using a Comprehensive History Phenotyping Instrument
NCT00772434
Vitamin D Repletion in Chronic Kidney Disease
NCT00772772
The Effect of Vitamin D Repletion on Insulin Resistance
NCT00606957
Physiological Effects of Androstadienone Exposure
NCT00553384
Characterization of T Cell Responses Following Yellow Fever Virus Vaccination in Healthy Adults
NCT00616356
The Metabolic Effects of Different Weight Loss Diets
NCT00422630
Standard Antiretroviral v. Multi-class Therapy in Acutely HIV-1 Infected Antiretroviral-Naïve Subjects (ADARC 2007-01)
NCT00525733
Study of a Potential Preventive Vaccine Against HIV in Healthy Volunteers
NCT00545987
Study of the Antiviral and Immunological Effects of Intensification of Suppressive Antiretroviral Therapy With Maraviroc
NCT00703586
Fructose-Induced Palmitate Synthesis in Overweight Subjects
NCT00535535
Studies of Biological Changes Related to Weight Loss After Gastric Bypass Surgery
NCT00120562
Autologous Dendritic Cells Pulsed With Autologous Apoptotic Tumor Cells Administered to Patients With Brain Tumors
NCT00893945
Characterization of Clonal B Cell Populations in HCV Infection
NCT00435201
Colorectal Inflammatory Response to a Western-Style Diet
NCT00932308
Dendritic Cell Vaccine Study (DC/PC3) for Prostate Cancer
NCT00345293
Immunotherapy of the Paraneoplastic Syndromes
NCT00378326
High Fat - High Protein Diet in the Treatment of Obesity
NCT00299273
Effect of Vitamin D and Calcium on Genes in the Colon
NCT00298545
Research on the Nature, Diagnosis, and Treatment of Obesity and Diabetes
NCT00229268
Relation of Obesity With Frequency of Meals (MST 0557)
NCT00229255
Study to Help Understand the Action of the Drug Etanercept for the Adult Patient With Psoriasis
NCT00116181
The Effect of Fructose on Blood Fats in Dialysis Patients and Healthy Volunteers
NCT00234156
High Carbohydrate vs. High Fat Diets in the Treatment of Obesity (JBR 0512)
NCT00123240
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 37 |
| Phase 2 | 6 |
| Phase 3 | 2 |
| Phase 4 | 5 |
Therapeutic Areas
What is open in the Rockefeller University pipeline
5 recruiting of 117 indexed (4% open); 92 completed (79%).
Phase mix: 7 late (III/IV) vs 43 early (I/II) (early-phase heavy).
Top condition: Obesity (5 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Rockefeller University: open-pipeline peers nationwide
Peers matched on 117 registered trials and 4% open enrollment, not the therapeutic-area sidebar.
Rockefeller University sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 117 trials (± recruiting share)
- San Diego State University · 118 trials · 27% recruiting
- Children's Hospital Los Angeles · 119 trials · 29% recruiting
- Jaeb Center for Health Research · 119 trials · 14% recruiting
- Medtronic - MITG · 119 trials · 4% recruiting
Sponsors near 4% open enrollment (± trial volume)
- Craig L Slingluff, Jr · 4% recruiting · 23 trials
- Esperion Therapeutics · 4% recruiting · 23 trials
- Tonix Pharmaceuticals · 4% recruiting · 23 trials
- National Institute on Drug Abuse (NIDA) · 4% recruiting · 335 trials
Related
What to do with this Rockefeller University page
117 registered trials is a research-attention snapshot, not an endorsement of Rockefeller University or any single study.
- 5 of Rockefeller University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Rockefeller University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Rockefeller University pipeline card: 117 registered trials from official public datasets.Report a data error.